3[1]Pauwels RA Buist AS,Calverley PMA,et al.Global strategy for the diag-nosis,management,and prevention of chronic obstructie pulmonary disease:NHIBI Global Iniiative for Chronic Obstructive Lung Disease(GOLD)Workshop Summary[J].Am J Respir Crit Med,2001,163(5):1256-1276.
4[2]Gan WQ,Man SF,Senthilselvan A,et al.Associadon between chronic ob-stuctive pulmonary disease and systemic inflammation:a systemadc:a systematic review and a meta-analysis[J].Thorax,2004,59(7):574-80.
5[4]Engstrom G,Lind P,Hedblad B,et al,Lung function and cardiovascuhr risk:rehtiomhip with inflammation-sensitive plasma proteins[J].Circuh-tion,2002,106:2555-2560.
6[5]Dahl M,Tybjaerg-Hansen A,Vestbo J,et al Elevated plasma fibrinogen associated wtth reduced pulmonary function and increased risk of chronic ob-structive pulmonary disease[J].Am J Respir Crit Care Med,2001,164:1008-1001.
7[6]Sin DD and Man P SF.Why Are Pafien With Chronic Obsmactive pul-monary Disease at Increased Risk of Cardiovascular iseases?:The Potential Role of systemic Inflammation in Chronic Obstructive Pulminary Disease[J].Circulation,2003.
8[7]Alessandri C,Basili S,Violi F,et al.Hypcrcoagulability state in patients with chronic obstructive pulmonary disease.Chronic Obstructive Bronvhifis and Haemostasis Group[J].Thromb Haemost,1994,72(3):343-346.
9罗慰恙.现代呼吸病学[M].北京:人民军区出版社,1997:300.
10orehek PJ, smith G, Grin aul C, et al. Airway. Response to Carbachol in normal andl asthma subjects[ J]. Am Rev Respir Dis,1997,115:937 -942.
4Nagai A. Pathology and pathophysiology of chronic obstructive pul- monary disease[ J]. Intern Med, 2002,41 (4) :265 - 269.
5SUGINO K, ISHIDA F, KIKUCHI N, et al. Comparison of clinical characteristics and prognostic factors of combined pul- monary fibrosis and emphysema versus idiopathic pulmonary fibrosis alone [J]. Respirology,2014,19(2) :239-245.
6RYERSON CJ, HARTMAN T, ELICKER BM, et al. Clini- cal features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis [J]. Chest,2013, 144( 1 ) :234-240.
7COTTIN V, LE PAVEC J, PREVOT G, et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome [J]. Eur Respir J, 2010,35 (1) : 105-111.
8EPAUD R, DELESTRAIN C, LOUHA M, et al. Combined pulmonary fibrosis and emphysema syndrome associated with ABCA3 mutations [J]. Eur Respir J,2014,43(2) : 638-641.
9GIRARD N, MARCHAND-ADAM S, NACCACHE JM, et al. Lung cancer in combined pulmonary fibrosis and emphy- sema: a series of 47 Western patients[J]. J Thorac Oncol, 2014,9(8) : 1162-1170.
10KIM YJ, SHIN SH, PARK JW, et al. Annual Change in Pulmonary Function and Clinical Characteristics of Combined Pulmonary Fibrosis and Emphysema and Idiopathic Pulmona- ry Fibrosis: Over a 3 Year Follow-up [J]. Tubere Respir Dis (Seoul) ,2014,77(1) : 18-23.
